Genzyme appoints M&F to handle kidney drug programme

Biotech company Genzyme has appointed Munro & Forster to handle a European PR programme for its kidney drug Renagel.

by Gemma O'Reilly

Sign in to continue

Sign in

Sign in

Trouble signing in?

Reset password: Click here

US and Asia
subscriptions@prweek.com
+001 (800) 558-1708

UK & Europe
support@prweek.com
+44 (0)20 8267 8121

Register

Don't have an account? Complete easy registration and receive:

Limited Article Views (Excludes Subscriber Only Content)
Select Newsletters (Excludes Subscriber Only Bulletins)

Register

FREE

Limited free articles a month
Limited number of free email bulletins

Subscribe to The Knowledge

To receive full access to PRWeek's content subscribe today and receive:

Unrestricted access to all The Information and The Knowledge content
Access to the new PRWeek Data Hub
Exclusive access to in-depth reports including the Top 150 UK PR Consultancies Report, Industry Awards Rankings, Industry Salaries Report, and more

Subscribe

To receive full access to PRWeek's content subscribe today and receive:

Unrestricted individual access to prweek.com
Breaking news and industry updates via PRWeek Daily News bulletin
Exclusive access to Agency Business Report, annual Salary Survey, Power List, 40 Under 40, & Best Places to Work, and more

Subscribe Options

The Power Book is here

SAVE 10% for a limited time only
Subscribe today to access:

Unlimited access to all news and Information content on prweek.com
Exclusive access to Power Book and Top 150 UK Agency Business Report
Essential regular round-ups such as Movers and Shakers, Pitch Update, Campaign round up and more

Need to activate your subscription?

Domain/Group Subscriptions
Click here >>

Individual Subscriptions
Click here >>

Need to activate your Subscription

Company Wide Subscriptions
Click here >>

UK Individual Subscribers
Click here >>

Recommended for you

Recommended for you

Explore further